CAS 1638744-06-5
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits trouvés.
Linagliptin Related Compound D ((R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C25H29BrN8O2Couleur et forme :Light Yellow PowderMasse moléculaire :552.15968(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
CAS :(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dioneFormule :C25H29BrN8O2Degré de pureté :96%Masse moléculaire :553.45Linagliptin Impurity K
CAS :Formule :C25H29BrN8O2Degré de pureté :96%Couleur et forme :SolidMasse moléculaire :553.4542Linagliptin EP Impurity D (Linagliptin USP Related Compound D)
CAS :Formule :C25H29BrN8O2Couleur et forme :Pale Yellow SolidMasse moléculaire :553.47N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin (E/Z Mixture)
CAS :Applications N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin is an impurity of Linagliptin (L465900); a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011)Formule :C25H29BrN8O2Couleur et forme :NeatMasse moléculaire :553.45
